148 related articles for article (PubMed ID: 32997867)
1. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
Murase Y; Iwata H; Takahara T; Tsuzuki T
Pathol Int; 2020 Dec; 70(12):984-991. PubMed ID: 32997867
[TBL] [Abstract][Full Text] [Related]
2. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
3. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
Kim H; Inomoto C; Uchida T; Furuya H; Komiyama T; Kajiwara H; Kobayashi H; Nakamura N; Miyajima A
Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
[TBL] [Abstract][Full Text] [Related]
4. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
5. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
Mehdi MZ; Nagi AH; Naseem N
Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
[TBL] [Abstract][Full Text] [Related]
6. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
Delahunt B; McKenney JK; Lohse CM; Leibovich BC; Thompson RH; Boorjian SA; Cheville JC
Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
[TBL] [Abstract][Full Text] [Related]
7. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
[TBL] [Abstract][Full Text] [Related]
8. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
9. Validation of the World Health Organization/International Society of Urological Pathology grading for Chinese patients with clear cell renal cell carcinoma.
Xiao Q; Yi X; Guan X; Yin H; Wang C; Zhang L; Pang Y; Li M; Gong G; Chen D; Liu L
Transl Androl Urol; 2020 Dec; 9(6):2665-2674. PubMed ID: 33457238
[TBL] [Abstract][Full Text] [Related]
10. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
11. [The WHO/ISUP grading system for renal carcinoma].
Moch H
Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
[TBL] [Abstract][Full Text] [Related]
13. WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.
Browning L; Colling R; Verrill C
Diagn Pathol; 2021 Aug; 16(1):75. PubMed ID: 34419085
[TBL] [Abstract][Full Text] [Related]
14. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.
Liu N; Gan W; Qu F; Wang Z; Zhuang W; Agizamhan S; Xu L; Yin J; Guo H; Li D
Am J Pathol; 2018 Apr; 188(4):929-936. PubMed ID: 29571325
[TBL] [Abstract][Full Text] [Related]
15. Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma.
Oh S; Sung DJ; Yang KS; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB
Acta Radiol; 2017 Mar; 58(3):376-384. PubMed ID: 27235451
[TBL] [Abstract][Full Text] [Related]
16. Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution.
Khor LY; Dhakal HP; Jia X; Reynolds JP; McKenney JK; Rini BI; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Sep; 40(9):1224-31. PubMed ID: 27428737
[TBL] [Abstract][Full Text] [Related]
17. Grading of renal cell carcinoma.
Delahunt B; Eble JN; Egevad L; Samaratunga H
Histopathology; 2019 Jan; 74(1):4-17. PubMed ID: 30565310
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Nuclear Morphometry and Ki-67 Index in Clear Cell Renal Cell Carcinomas: a Five-Year Study.
Sheela Devi CS; Suchitha S; Veerendrasagar RS
Iran J Pathol; 2017; 12(2):150-157. PubMed ID: 29515637
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224-1231.
Kryvenko ON
Urol Oncol; 2017 Jun; 35(6):454-455. PubMed ID: 28416108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
